Oncology News | pharmaphorum

News

A new treatment regimen for advanced bladder cancer combining MSD's Keytruda with Astellas' Padcev has been given the green light for NHS use.

News

Merck unit SpringWorks has claimed EU approval for Ogsiveo, becoming the first approved therapy for desmoid tumours in Europe.

News

A newly approved AI from Artera can guide treatment and predict prognosis in people diagnosed with localised prostate cancer.

News

Researchers in the US have found that subtle changes in the sound of a voice could be used to detect if someone has cancer of the larynx.

News

Astellas and Pfizer plan to file Padcev for earlier-stage bladder cancer after showing a survival benefit in a combination regimen with Keytruda.

News

Bayer has joined the throng of drugmakers developing KRAS-targeting therapies for cancer, via an alliance with San Diego biotech Kumquat.